|Other Names||Protein prune homolog, hPrune, Drosophila-related expressed sequence 17, DRES-17, DRES17, HTcD37, PRUNE|
|Format||Synthetic peptide was lyophilized with 100% acetonitrile and is supplied as a powder. Reconstitute with 0.1 ml DI water for a final concentration of 1 mg/ml.|
|Storage||Maintain refrigerated at 2-8°C for up to 6 months. For long term storage store at -20°C.|
|Precautions||This product is for research use only. Not for use in diagnostic or therapeutic procedures.|
|Function||Phosphodiesterase (PDE) that has higher activity toward cAMP than cGMP, as substrate. Plays a role in cell proliferation, is able to induce cell motility and acts as a negative regulator of NME1.|
|Cellular Location||Cytoplasm. Nucleus. Cell junction, focal adhesion. Note=In some transfected cells a nuclear staining is also observed|
|Tissue Location||Ubiquitously expressed. Seems to be overexpressed in aggressive sarcoma subtypes, such as leiomyosarcomas and malignant fibrous histiocytomas (MFH) as well as in the less malignant liposarcomas|
firstname.lastname@example.org, and receive a free "I Love Antibodies" mug.
Provided below are standard protocols that you may find useful for product applications.
Phosphodiesterase (PDE) that has higher activity toward cAMP than cGMP, as substrate. It plays a role in cell proliferation, is able to induce cell motility and acts as a negative regulator of NME1.
Vieira, A.R., et al. Genet. Med. 10(9):668-674(2008)Middelhaufe, S., et al. Biochem. J. 407(2):199-205(2007)Kobayashi, T., et al. Mol. Cell. Biol. 26(3):898-911(2006)Zollo, M., et al. Clin. Cancer Res. 11(1):199-205(2005)Forus, A., et al. Oncogene 20(47):6881-6890(2001)Reymond, A., et al. Oncogene 18(51):7244-7252(1999)
If you have any additional inquiries please email technical services at email@example.com.